$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%
Morning BriefingTuesday, Jun 9, 2026
Buy Zone5 picks: ONDS, SMCI, NVTS…
Exit Alerts0 warnings issued
Fear & GreedGREED67
SPY ETF+0.78% (Pre-Market)
Livesync 0s ago

$ARTV

ARTV
NASDAQ · Mid Cap
$5.23-2.61%
52W HIGH: $7.75

Backed by 2 cross-validated callers

43d max lead · Closed at +389% from earliest mention

The alpha source
Ranked by lead days
JE
@JeffTheOmega1
Discovery Score: 0.23
See Caller Page →
43d
Lead Time

“$ARTV Recent IPO Nah shes not going to get pushed from down here lol”

Tweeted Aug 13, 2024View Original
AI
@ainvest_vision
Discovery Score: 0.39
See Caller Page →
42d
Lead Time

“Updated Top Bullish Price Targets! Stocks that having positive rating from analysts and have the top price potential upside are $ANVS $DDI $ARTV $SPRY $BVS #AInvest #trading #liveanalysis #investor #investors”

Tweeted Aug 14, 2024View Original
DH
@dhovekamp42
Discovery Score: 0.26
See Caller Page →
42d
Lead Time

“No, but an interesting idea - indeed they may merge before a buyout so. A 20:80 to 25:75 merger would value Affimed at $1b and perhaps could look fair and very attractive for all: $AFMD , $ARTV , and $RHHBY or other Big bidder.”

Tweeted Aug 14, 2024View Original
BI
@BiotechTV
Discovery Score: 0.23
See Caller Page →
40d
Lead Time

“Company News: Checking in with @ArtivaBio 's CEO Fred Aslan after the NK cell focused company's $167 million IPO. $ARTV Full video: biotechtv.com/post/artiva-bi…”

Tweeted Aug 16, 2024View Original
MA
@MarcJacksonLA
Discovery Score: 0.71
See Caller Page →
27d
Lead Time

“- $ARTV - Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - globenewswire.com/news-relea…”

Tweeted Aug 29, 2024View Original
AR
@ArtivaBio
Discovery Score: 0.22
See Caller Page →
27d
Lead Time

“Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights investors.artivabio.com/News… $ARTV #AlloNK #lupus #NKcell #NKcells #NKcelltherapy #autoimmunedisease #cancer”

Tweeted Aug 29, 2024View Original
BI
@Biotech2k1
Discovery Score: 0.27
See Caller Page →
24d
Lead Time

“$ARTV has a pipeline of alloNK cell programs for CD19 in Autoimmune and Oncology.”

Tweeted Sep 1, 2024View Original
BI
@bioscifiryan
Discovery Score: 0.17
See Caller Page →
23d
Lead Time

“I'd wait for lockup to expire before making a move, but $ARTV 's pipeline value does look promising.”

Tweeted Sep 2, 2024View Original
WH
@whalewisdom
Discovery Score: 0.17
See Caller Page →
22d
Lead Time

“New SC 13D/A from RA CAPITAL MANAGEMENT, L.P. concerning $ARTV . See details at whalewisdom.com/filing/ra-ca…”

Tweeted Sep 3, 2024View Original
Theme Context
Primary Theme
Biotech (oncology / dermatology / rare disease)
Flags35 of 432 callers
Avg Lead17d
Realized+305.0%
Related in theme
$STRO8
+10.50%
$MANE7
+2.54%
$SNSE7
-8.57%
Strategy Consensus
0/5 strategies firing currently
Run History
+389%
Peak
43d
Max Lead
Market Action
Market ActionChart coming soon